Dr. Strauss is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20455 Lorain Rd
Suite T-03
Fairview Park, OH 44126Phone+1 440-333-2003Fax+1 440-333-3309
Education & Training
- Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalResidency, Pediatrics, 1975 - 1976
- University of Colorado School of Medicine/National Jewish Health (Adult)Fellowship, Allergy and Immunology, 1974 - 1975
- The MetroHealth System/Case Western Reserve UniversityResidency, Pediatrics, 1972 - 1974
- State University of New York Downstate Medical Center College of MedicineClass of 1972
Certifications & Licensure
- OH State Medical License 1975 - 2026
- CO State Medical License 1974 - 1978
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- 3 citationsLong-Term Efficacy and Safety Among Patients With Severe Eosinophilic Asthma Treated With Mepolizumab and Its Effect on Small Airways.Ronald Strauss, Hannah Leflein, Anna Kolesar, Jeffrey Hammel
The Journal of Allergy and Clinical Immunology. in Practice. 2023-12-01 - 17 citationsEosinophilia Is Associated with Improved COVID-19 Outcomes in Inhaled Corticosteroid-Treated Patients.Joe G Zein, Ronald Strauss, Amy H Attaway, Bo Hu, Alex Milinovich
The Journal of Allergy and Clinical Immunology. in Practice. 2022-03-01 - 1 citationsReply to "A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter".Ronald Strauss, Amy H Attaway, Joe G Zein
The Journal of Allergy and Clinical Immunology. in Practice. 2022-01-01
Journal Articles
- Subcutaneous Terbutaline as an Alternative to Metered-Dose Inhalers for Asthma During the COVID-19 PandemicRonald Strauss, MD, Journal of the American College of Emergency Physicians Open
Press Mentions
- Nasal Steroid Sprays Could Be Effective at Preventing Serious Cases of COVID, Study FindsOctober 26th, 2021
- Cleveland Clinic Potential Breakthrough: Steroid-Based Nasal Spray Can Significantly Reduce Impact of COVID-19October 1st, 2021
- Cleveland Clinic Study Suggests Steroid Nasal Sprays May Help Improve Outcomes in Severe COVID-19 DiseaseSeptember 28th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: